Unlocking the spatial dimension: Maximizing insights from spatial omics data
Watch our in-depth webinar delving into the cutting-edge realm of spatial omics technologies.
In this webinar, experts from BioLizard and Pixelgen Technologies guide you through how spatial omics can deepen your biological understanding by preserving spatial context within molecular analyses.
We will present an introduction to the pioneering molecular pixelation method for single cell spatial proteomics, and share insights into analysis of spatial omics data and integration of different omics data types - drawing on real-life case studies.
If you are a biotech professional interested in leveraging spatial technologies, and want more information on the advantages and details of utilizing the technology, this webinar is for you. Don’t miss this opportunity to explore the frontier of spatial omics and its implications for precision medicine, drug discovery, and beyond.
Want to learn more about spatial technologies?
Read our article on spatial transcriptomics and its added value
Spatial data is emerging as a new way to improve understanding of mechanisms of action underlying disease states. Improved understanding of disease mechanisms and modes of action leads to better clinical trial design. This enables the identification and validation of robust biomarkers, which aid in patient stratification and optimization of trial design. High-throughput single-cell omics screening and diagnostics are rapidly becoming a reality, and similar opportunities are expected with spatial technologies in the future.
In this article written by our in-house expert Dr. Viacheslav Mylka, you can find further information about the added biological and scientific value that spatial transcriptomics in particular may bring for your research projects.
Read our article on "Trends in single cell sequencing: Spatial transcriptomics"
In this article, we explain applications and analysis of spatial transcriptomics, and predict where these methodologies will go in the future.
